Advances in paediatric rheumatology: Beyond NSAIDs and joint replacement

Journal of Paediatrics and Child Health

Volumn 40, Issue 4, 2004, Pages 161-169

  Munro, J E ^a   Murray, K J ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Biological agents; Juvenile arthritis; Methotrexate; Paediatric rheumatology

Indexed keywords

ACETYLSALICYLIC ACID; ANTIRHEUMATIC AGENT; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DICLOFENAC; GLUCOSAMINE DERIVATIVE; HEXACETONIDE; HYALURONIC ACID; HYDROXYCHLOROQUINE; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; LEFLUNOMIDE; MELOXICAM; METHOTREXATE; METHYLPREDNISOLONE; MIDAZOLAM; NAPROXEN; NITROUS OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PREDNISOLONE; ROFECOXIB; SALAZOSULFAPYRIDINE; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW SUPPRESSION; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; DEMYELINATING DISEASE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE MARKER; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG INDUCED CANCER; EPIDEMIOLOGICAL DATA; GASTROINTESTINAL SYMPTOM; GENETIC ASSOCIATION; HUMAN; IDIOPATHIC DISEASE; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY DIAGNOSIS; LIVER DISEASE; MUSCLE CONTRACTURE; OCCUPATIONAL THERAPY; ONSET AGE; PATHOGENESIS; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REMISSION; REVIEW; RHEUMATIC DISEASE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, JUVENILE RHEUMATOID; ARTHROPLASTY, REPLACEMENT; HUMANS; MULTICENTER STUDIES; PEDIATRICS; RHEUMATOLOGY; STEM CELL TRANSPLANTATION;

EID: 2342526030     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2004.00356.x     Document Type: Review

References (49)

1. Kurtin PS. Outcomes assessment: meeting the challenge of accountability in pediatric rheumatology. J. Rheumatol. 2000; 27: S8-S10.
2. Cuesta IA, Kerr K, Simpson P, Jarvis JN. Subspecialty referrals for pauciarticular juvenile rheumatoid arthritis. Arch. Pediatr. Adolesc. Med. 2000; 154: 122-5.
3. Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis. Why does it vary so much? J. Rheumatol. 2002; 29: 1520-30.
4. Petty RE, Southwood TR, Baum J et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J. Rheumatol. 1998; 25: 1991-4.
5. Southwood TR. Classifying childhood arthritis. Ann. Rheum. Dis. 1997; 56: 79-82.
6. Murray K, Thompson SD, Glass DN. Pathogenesis of juvenile chronic arthritis: genetic and environmental factors. Arch. Dis Child. 1997; 77: 530-4.
7. Petty RE. Frequency of uncommon diseases: is juvenile idiopathic arthritis under recognised? J. Rheumatol. 2002; 29: 1356-7.
8. Glass DN, Giannini EH. Juvenile rheumatoid arthritis as a complex genetic trait. Arthritis Rheum. 1999; 42: 2261-8.
9. Moroldo MB, Tague BL, Shear ES, Glass DN, Giannini EH. Juvenile rheumatoid arthritis in affected sibpairs. Arthritis Rheum. 1997; 40: 1962-6.
10. Thomson W, Donn R. Juvenile idiopathic arthritis genetics - what's new? What's next? Arthritis Res. 2002; 4: 302-6.
11. Massa M, Mazzoli F, Pignatti P et al. Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. Arthritis Rheum. 2002; 46: 2721-9.
12. Prakken B, Kuis W, Van Eden W, Albani S. Heat shock proteins in juvenile idiopathic arthritis: keys for understanding remitting arthritis and candidate antigens for immune therapy. Curr. Rheumatol. Rep. 2002; 4: 466-73.
13. Davies K, Stiehm ER, Woo P, Murray KJ. Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. J. Rheumatol. 2001; 28: 2326-34.
14. Illowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics 2002; 109: 109-15.
15. Huemer C, Malleson PN Cabral DA et al. Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis. J. Rheumatol. 2002; 29: 1531-5.
16. Al-Matar MJ, Petty RE, Tucker LB, Malleson PN, Schroeder ML, Cabral DA. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis. Arthritis Rheum. 2002; 46: 2708-15.
17. Modesto C, Woo P, Garcia-Consuegra J et al. Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. Clin. Exp. Rheumatol. 2001; 19: 211-17.
18. Hromadnikova I, Stechova K, Pavla V et al. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Autoimmunity 2002; 35: 397-401.
19. Miller ML. Use of imaging in the differential diagnosis of rheumatic diseases in children. Rheum. Dis. Clin. North Am. 2002; 28: 483-92.
20. Cassidy JT, Petty RE. Juvenile ankylosing spondylitis. In: Cassidy JT, Petty RE (eds). Textbook of Pediatric Rheumatology, 4th edn. Philadelphia: WB Saunders, 2001; 334-7.
21. Frosch M, Foell D, Ganser G, Roth J. Arthrosonography of hip and knee joints in the follow up of juvenile rheumatoid arthritis. Ann. Rheum. Dis. 2003; 62: 242-4.
22. Johnson K, Wittkop B, Haigh F, Ryder C, Gardner-Medwin JM. The early magnetic resonance imaging features of the knee in juvenile idiopathic arthritis. Clin. Radiol. 2002; 57: 466-71.
23. Gylys-Morin VM, Graham TB, Blebea JS et al. Knee in early juvenile rheumatoid arthritis: MR imaging findings. Radiology 2001; 220: 696-706.
24. Lamer S, Sebag GH. MRI and ultrasound in children with juvenile chronic arthritis. Eur. J. Radiol. 2000; 33: 85-93.
25. Argyropoulou MI, Fanis SL, Xenakis T, Efremidis SC, Siamopoulou A. The role of MRI in the evaluation of hip joint disease in clinical subtypes of juvenile idiopathic arthritis. Br. J. Radiol. 2002; 75: 229-33.
26. Hackett J, Johnson B, Parkin A, Southwood T. Paediatric rheumatology: clinical practice review. Physiotherapy and occupational therapy for juvenile chronic arthritis: custom and practice in five centres in the UK, USA and Canada. Rheumatology 1996; 35: 695-9.
27. Murray KJ, Lovell DJ. Advanced therapy for juvenile arthritis. Best Pract. Res. Clin. Rheumatol. 2002; 16: 361-78.
28. Hagen LE, Schneider R, Stephens D, Modrusan D, Feldman BM. Use of complementary and alternative medicine by pediatric rheumatology patients. Arthritis Rheum. 2003; 49: 3-6.
29. Sherry DD, Stein LD, Reed AM, Schanberg LE, Kredich DW. Prevention of leg length discrepancy in young children with pauci-articular juvenile rheumatoid arthritis by treatment with intra-articular steroids. Arthritis Rheum. 1999; 42: 2330-4.
30. Huppertz HI, Tschammler A, Horwitz AE, Schwab KO. Intra-articular corticosteroids for chronic arthritis in children. Efficacy and effects on cartilage and growth. J. Pediatr. 1995; 127: 317-21.
31. Cleary AG, Murphy HD, Davidson JE. Intra-articular corticosteroid injections in juvenile idiopathic arthritis. Arch. Dis. Child. 2003; 88: 192-6.
32. Adebajo AO, Hall MA. The use of intravenous pulsed methyl-prednisolone in the treatment of systemic-onset juvenile chronic arthritis. Br. J. Rheumatol. 1998; 37: 1240-2.
33. Ramanan AV, Whitworth P, Baildam EM. Use of methotrexate in juvenile idiopathic arthritis. Arch. Dis. Child. 2003; 88: 197-200.
34. Giannini EH, Brewer EJ, Kuzmina N et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N. Engl. J. Med. 1992; 326: 1043-9.
35. Hashkes PJ, Balistreri WF, Bove KE, Ballard ET, Passo MH. The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J. Pediatr. 1999; 134: 47-52.
36. Gerloni V, Comaz R, Gattinara M, Arnoldi C, Pontikaki I, Fantini F. Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study. Rheumatology 2001; 40: 907-13.
37. Wedderburn LR, Abinun M, Palmer P, Foster HE. Autologous haematopoeitic stem cell transplantation in juvenile idiopathic arthritis. Arch. Dis. Child. 2003; 88: 201-5.
38. Wilkinson N, Jackson G, Gardner-Medwin J. Biologic therapies for juvenile arthritis. Arch. Dis. Child. 2003; 88: 186-91.
39. Grom AA, Murray KJ, Luyrink L et al. Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy. Arthritis Rheum. 1996; 39: 1703-10.
40. Lovell DJ, Giannini EH, Reiff A et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N. Engl. J. Med. 2000; 342: 763-9.
41. Lovell DJ, Giannini EH, Reiff A et al. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum. 2003; 48: 218-26.
42. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997; 40: 1202-9.
43. Foster HE, Marshall N, Myers A, Dunkley P, Griffiths I. Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum. 2003; 48: 767-75.
44. Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: education and employment. Rheumatology 2002; 41: 1436-9.
45. McDonagh JE, Southwood TR, Ryder CA. Bridging the gap in rheumatology. Ann. Rheum. Dis. 2000; 59: 86-93.
46. Petty RE, Smith JR, Rosenbaum JT. Arthritis and uveitis in children. A pediatric rheumatology perspective. Am. J. Ophthalmol. 2003; 135: 879-84.
47. Murray KJ, Laxer RM. Scleroderma in children and adolescents. Rheum. Dis. Clin. North Am. 2002; 28: 603-24.
48. Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr. Opin. Rheumatol. 2003; 15: 61-9.
49. Murray KJ, Woo P. Benign joint hypermobility in childhood. Rheumatology (Oxford) 2001; 40: 489-91.